查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1782950

全球神經科技設備市場

Neurotech Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 296 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 2030 年全球神經科技設備市場規模將達 303 億美元

全球神經技術設備市場規模預計在2024年達到152億美元，預計在分析期（2024-2030年）內將以12.2%的複合年成長率成長，到2030年將達到303億美元。神經刺激是本報告分析的細分市場之一，預計其複合年成長率將達到10.4%，到分析期結束時達到124億美元。神經假體細分市場在分析期間的複合年成長率預計為14.9%。

美國市場規模估計為 41 億美元，中國市場預計複合年成長率為 16.1%

預計2024年，美國神經科技設備市場規模將達41億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到63億美元，在2024-2030年的分析期間內，複合年成長率將達到16.1%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為9.1%和10.7%。在歐洲，預計德國市場的複合年成長率約為9.6%。

全球神經科技設備市場—主要趨勢與促進因素摘要

神經技術設備如何徹底改變腦機互動和神經健康？

神經技術設備正在改變人類與科技的互動方式，實現腦機介面 (BCI)、神經刺激療法、認知增強和即時神經監測。這些設備彌合了神經科學與數位技術之間的差距，為癲癇、憂鬱症、帕金森氏症和脊髓損傷等疾病提供了突破性的解決方案。腦植入、穿戴式神經刺激設備和基於非侵入性腦電圖的系統使人們能夠恢復運動矯正器具義肢使用神經訊號進行交流。神經技術在心理健康治療中也發揮著重要作用，經顱磁刺激 (TMS) 和迷走神經刺激 (VNS) 正在成為抗治療性憂鬱症和焦慮症的有效治療方法。神經回饋設備在認知訓練、注意力改善和壓力管理方面的應用日益廣泛，進一步擴展了神經技術的範圍。人工智慧 (AI) 和機器學習的進步使得即時神經數據分析成為可能，為精準神經治療鋪平了道路。隨著全球人口老化和神經退化性疾病日益普遍，神經技術設備擴大被融入主流醫療保健，以透過直接的腦機互動來增強神經復健並拓展人類潛能。

哪些挑戰阻礙了神經技術設備的普及？

儘管神經科技設備發展迅速，仍面臨許多挑戰，阻礙其廣泛應用。其中一個主要障礙是開發和部署成本高昂，尤其是植入式腦機介面 (BCI) 和先進的神經調節療法。圍繞腦機介面和神經刺激技術的倫理和監管問題也構成了另一個障礙，因為長期安全性、隱私以及神經資料的潛在濫用仍然是亟待解決的問題。解讀腦波訊號的複雜性和患者反應的多變性也對神經科技應用的可靠性和有效性提出了挑戰。許多神經科技設備需要強大的運算能力和即時處理能力，這引發了人們對能耗和設備小型化的擔憂。此外，人們對侵入式腦植入的質疑以及對連網神經科技解決方案資料安全性的擔憂，正在減緩其應用速度。各種神經科技平台之間的標準化以及與現有醫療保健系統的互通性方面仍存在一些尚未解決的問題，這使得將其整合到臨床工作流程中更具挑戰性。應對這些挑戰需要加強對神經倫理學的投入，促進神經科學家和工程師之間的跨學科合作，並開發低功耗無線神經科技解決方案，以提高使用者的可及性和安全性。

哪些創新正在突破神經科技的界限？

神經科技市場正經歷快速的技術創新，新技術不斷提升腦機介面和神經調節設備的功能性、準確性和可近性。高密度軟性神經植入的開發改進了腦波訊號採集，並擴展了設備性能。人工智慧驅動的腦機介面 (BCI) 能夠更快、更準確地解碼神經活動，為直接控制思維的裝置打開了大門。功能性近紅外線光譜 (fNIRS) 和乾電極腦電圖耳機等非侵入式神經技術解決方案的興起，使得神經技術更容易應用於消費性應用，包括遊戲、生產力和冥想。神經刺激技術也不斷發展，閉合迴路回饋系統可以根據即時腦活動自動調整刺激參數，從而提高其對癲癇和慢性疼痛等疾病的療效。無線神經技術的進步實現了腦感測器和外部設備之間的無縫連接，減少了對侵入性手術的需求。此外，神經技術與擴增實境(AR) 和虛擬實境 (VR) 的融合，正在為認知療法、疼痛管理和神經復健領域開啟新的可能性。隨著科技創新的加速，神經科技正變得更加複雜、個人化，並日益融入日常生活，進而改變人機互動的未來。

是什麼推動了神經技術設備市場的成長？

神經技術設備市場的成長受到多種因素的推動，包括神經系統疾病盛行率的上升、對腦機介面研究的投入增加以及消費者對認知增強技術日益成長的興趣。隨著非侵入性植入式裝置獲得 FDA核准用於治療癲癇、憂鬱症和帕金森氏症等疾病，對神經刺激療法的需求正在激增。人工智慧主導的腦機介面的擴展進一步推動了市場成長，公司正在開發意念控制的義肢、輔助通訊工具和免持運算解決方案。穿戴式神經技術在健康和心理健康領域的應用日益廣泛，例如用於改善睡眠和減輕壓力的神經回饋設備，正在將市場擴展到臨床應用之外。對個人化醫療和即時腦監測的推動正在推動對下一代腦電圖和神經成像成像技術的投資，從而提高神經系統診斷的準確性。此外，支持神經技術研究的政府舉措，如美國腦舉措和歐洲人腦計劃，正在刺激創新和商業化。隨著神經技術設備的不斷發展，其應用將擴展到醫療保健、消費技術、國防和人類增強，並有望在未來幾年實現快速的市場成長。

部分

產品類型（神經刺激、神經修復、神經感測、神經復健）、病情類型（巴金森氏症、疼痛管理、認知障礙、癲癇、尿失禁和大便失禁、聽力障礙、憂鬱症、睡眠障礙）

受訪公司範例

  • BioSerenity
  • Blackrock Neurotech
  • BrainCo
  • Brainlab
  • Cala Health
  • Ceribell
  • Cognito Therapeutics
  • Elekta
  • Emotiv
  • Empatica
  • Flow Neuroscience
  • Inbrain Neuroelectronics
  • Kernel
  • Motif Neurotech
  • Nalu Medical
  • Neurable
  • Neuralink
  • NeuroOne Medical Technologies
  • Neurovalens
  • Synchron

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自世界各地專家的精選內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP32330

Global Neurotech Devices Market to Reach US$30.3 Billion by 2030

The global market for Neurotech Devices estimated at US$15.2 Billion in the year 2024, is expected to reach US$30.3 Billion by 2030, growing at a CAGR of 12.2% over the analysis period 2024-2030. Neurostimulation, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$12.4 Billion by the end of the analysis period. Growth in the Neuroprostheses segment is estimated at 14.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.1 Billion While China is Forecast to Grow at 16.1% CAGR

The Neurotech Devices market in the U.S. is estimated at US$4.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.3 Billion by the year 2030 trailing a CAGR of 16.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.1% and 10.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.

Global Neurotech Devices Market - Key Trends & Drivers Summarized

How Are Neurotech Devices Revolutionizing Brain-Computer Interaction and Neural Health?

Neurotech devices are transforming the way humans interact with technology, enabling brain-computer interfaces (BCIs), neurostimulation therapies, cognitive enhancement, and real-time neurological monitoring. These devices bridge the gap between neuroscience and digital technology, offering groundbreaking solutions for conditions such as epilepsy, depression, Parkinson’s disease, and spinal cord injuries. Brain implants, wearable neurostimulation devices, and non-invasive EEG-based systems are enabling individuals to regain mobility, control prosthetics, and communicate using neural signals. Neurotech is also playing a crucial role in mental health treatment, with transcranial magnetic stimulation (TMS) and vagus nerve stimulation (VNS) emerging as effective therapies for treatment-resistant depression and anxiety disorders. The growing adoption of neurofeedback devices for cognitive training, focus improvement, and stress management is further expanding the neurotech landscape. Advances in artificial intelligence (AI) and machine learning are enabling real-time neural data analysis, paving the way for precision neurotherapies. As the global population ages and neurodegenerative disorders become more prevalent, neurotech devices are increasingly being integrated into mainstream healthcare, enhancing neurological rehabilitation and expanding human potential through direct brain-machine interaction.

What Challenges Are Slowing the Adoption of Neurotech Devices?

Despite rapid advancements, neurotech devices face several challenges that hinder widespread adoption. One of the key obstacles is the high cost of development and implementation, particularly for implantable BCIs and advanced neuromodulation therapies. Ethical and regulatory concerns surrounding brain-computer interfaces and neurostimulation technologies pose additional hurdles, as long-term safety, privacy, and potential misuse of neurodata remain pressing concerns. The complexity of brain signal interpretation and variability in patient responses also challenge the reliability and effectiveness of neurotech applications. Many neurotech devices require significant computational power and real-time processing capabilities, leading to concerns about energy consumption and device miniaturization. Additionally, public skepticism regarding invasive brain implants and concerns over data security in connected neurotech solutions slow adoption rates. Standardization across different neurotech platforms and interoperability with existing healthcare systems remain unresolved issues, making integration into clinical workflows more difficult. Addressing these challenges requires increased investment in neuroethics, cross-disciplinary collaboration between neuroscientists and engineers, and advancements in low-power, wireless neurotech solutions that improve user accessibility and safety.

How Are Innovations Pushing the Boundaries of Neurotech?

The neurotech market is undergoing rapid innovation, with new technologies enhancing the functionality, accuracy, and accessibility of brain-machine interfaces and neuromodulation devices. The development of high-density, flexible neural implants is allowing for improved brain signal acquisition and longer-lasting device performance. AI-powered BCIs are enabling faster and more accurate decoding of neural activity, opening doors for direct thought-controlled devices. The rise of non-invasive neurotech solutions, such as functional near-infrared spectroscopy (fNIRS) and dry-electrode EEG headsets, is making neurotechnology more accessible for consumer applications, including gaming, productivity enhancement, and meditation. Neurostimulation is also evolving, with closed-loop feedback systems that automatically adjust stimulation parameters based on real-time brain activity, improving efficacy for conditions such as epilepsy and chronic pain. Advances in wireless neurotech are enabling seamless connectivity between brain sensors and external devices, reducing the need for invasive procedures. Additionally, the convergence of neurotech with augmented reality (AR) and virtual reality (VR) is opening new possibilities in cognitive therapy, pain management, and neurorehabilitation. As innovation accelerates, neurotech is becoming more sophisticated, personalized, and integrated into everyday life, transforming the future of human-computer interaction.

What Is Driving the Growth of the Neurotech Devices Market?

The growth in the neurotech devices market is driven by several factors, including the increasing prevalence of neurological disorders, rising investments in brain-machine interface research, and growing consumer interest in cognitive enhancement technologies. The demand for neurostimulation therapies is surging as non-invasive and implantable devices gain FDA approvals for conditions such as epilepsy, depression, and Parkinson’s disease. The expansion of AI-driven brain-computer interfaces is further fueling market growth, with companies developing mind-controlled prosthetics, assistive communication tools, and hands-free computing solutions. The growing adoption of wearable neurotech in wellness and mental health, including neurofeedback devices for sleep improvement and stress reduction, is expanding the market beyond clinical applications. The push for personalized medicine and real-time brain monitoring is driving investment in next-generation EEG and neuroimaging technologies, enhancing the precision of neurological diagnostics. Additionally, government initiatives supporting neurotechnology research, such as the U.S. BRAIN Initiative and the European Human Brain Project, are fostering innovation and commercialization. As neurotech devices continue to evolve, their applications are expanding across healthcare, consumer technology, defense, and human augmentation, positioning the market for rapid growth in the coming years.

SCOPE OF STUDY:

The report analyzes the Neurotech Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Neurostimulation, Neuroprostheses, Neurosensing, Neurorehabilitation); Condition Type (Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy, Urinary & Fecal Incontinence, Hearing Conditions, Depression, Sleep Disorders)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • BioSerenity
  • Blackrock Neurotech
  • BrainCo
  • Brainlab
  • Cala Health
  • Ceribell
  • Cognito Therapeutics
  • Elekta
  • Emotiv
  • Empatica
  • Flow Neuroscience
  • Inbrain Neuroelectronics
  • Kernel
  • Motif Neurotech
  • Nalu Medical
  • Neurable
  • Neuralink
  • NeuroOne Medical Technologies
  • Neurovalens
  • Synchron

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Neurotech Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Neurological Disorders Spurs Demand for Advanced Neurotech Solutions
    • Rising Investment in Brain-Computer Interface (BCI) Research Expands Addressable Market Opportunity
    • Increasing Integration of AI and Machine Learning in Neurotech Devices Strengthens Business Case for Adoption
    • Heightened Consumer Interest in Cognitive Enhancement Technologies Drives Demand for Wearable Neurotech
    • Surge in Mental Health Awareness Throws the Spotlight on Non-Invasive Neuromodulation Therapies
    • Rapid Advancements in Miniaturization and Implantable Device Technology Propel Growth in Medical Neurodevices
    • Adoption of Personalized Neurological Therapies Accelerates Demand for Patient-Centric Neurotech Solutions
    • Favorable Regulatory Approvals for Novel Neurostimulation Devices Sustain Growth Momentum
    • Rise in Telehealth and Remote Monitoring Trends Drives Adoption of Connected Neurotech Platforms
    • Growing Use of Neurotech Devices in Rehabilitation and Stroke Recovery Expands Clinical Application Scope
    • Increasing Demand for Non-Pharmacological Treatment Alternatives Generates Opportunity for Neurotherapy Devices
    • Military and Defense Interest in Cognitive Augmentation Technologies Opens Up New Strategic Market Frontiers
    • Aging Global Population and Increasing Incidence of Neurodegenerative Diseases Drive Device Penetration
    • Integration of Cloud and Big Data Analytics in Neurological Monitoring Enhances Market Attractiveness
    • Venture Capital and Strategic Partnerships in Neurotech Innovation Accelerate Market Commercialization
    • Emergence of Consumer Neurotech in Wellness and Gaming Sectors Drives Market Diversification
    • High Cost of R&D and Commercialization Challenges Present Barriers to Entry for Emerging Players
    • Growing Use of EEG and Neuroimaging in Brain Research Spurs Demand for Advanced Diagnostic Tools
    • Evolving Regulatory Landscape and Reimbursement Policies Shape Market Dynamics and Access
    • Increasing Cross-Disciplinary Collaboration in Neuroscience, Engineering, and Data Science Fuels Innovation Pipeline
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurotech Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurotech Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Neurostimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Neurostimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Neurostimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neuroprostheses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neuroprostheses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Neuroprostheses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Neurosensing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Neurosensing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Neurosensing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neurorehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neurorehabilitation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Neurorehabilitation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hearing Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hearing Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hearing Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Depression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Depression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Sleep Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Sleep Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Sleep Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Parkinson's Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Parkinson's Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Cognitive Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Cognitive Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Cognitive Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Urinary & Fecal Incontinence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Urinary & Fecal Incontinence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • CHINA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Neurotech Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Italy 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: UK 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Spain 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Spain 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Russia 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Russia 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Neurotech Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Australia 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Australia 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • INDIA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: India 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: India 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: South Korea 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: South Korea 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Neurotech Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Latin America 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Latin America 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Latin America 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Argentina 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Argentina 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Brazil 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Brazil 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Mexico 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Mexico 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Latin America 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Neurotech Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Middle East 15-Year Perspective for Neurotech Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Middle East 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Middle East 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Iran 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Iran 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Israel 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Israel 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Saudi Arabia 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: UAE 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: UAE 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Rest of Middle East 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030
  • AFRICA
    • Neurotech Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Neurotech Devices by Product Type - Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Africa 15-Year Perspective for Neurotech Devices by Product Type - Percentage Breakdown of Value Sales for Neurostimulation, Neuroprostheses, Neurosensing and Neurorehabilitation for the Years 2015, 2025 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Neurotech Devices by Condition Type - Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Africa 15-Year Perspective for Neurotech Devices by Condition Type - Percentage Breakdown of Value Sales for Hearing Conditions, Depression, Sleep Disorders, Parkinson's Disease, Pain Management, Cognitive Disorders, Epilepsy and Urinary & Fecal Incontinence for the Years 2015, 2025 & 2030

IV. COMPETITION